US20020077653A1 - Hemostatic system for body cavities - Google Patents
Hemostatic system for body cavities Download PDFInfo
- Publication number
- US20020077653A1 US20020077653A1 US09/998,524 US99852401A US2002077653A1 US 20020077653 A1 US20020077653 A1 US 20020077653A1 US 99852401 A US99852401 A US 99852401A US 2002077653 A1 US2002077653 A1 US 2002077653A1
- Authority
- US
- United States
- Prior art keywords
- balloon
- central tube
- fabric
- tube
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12104—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in an air passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/24—Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/70—Manipulators specially adapted for use in surgery
- A61B34/76—Manipulators having means for providing feel, e.g. force or tactile feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10181—Means for forcing inflation fluid into the balloon
- A61M25/10183—Compressible bulbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
- A61B2017/0053—Loading magazines or sutures into applying tools
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00632—Occluding a cavity, i.e. closing a blind opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00818—Treatment of the gastro-intestinal system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00898—Material properties expandable upon contact with fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
- A61B2090/065—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring contact or contact pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1081—Balloon catheters with special features or adapted for special applications having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0618—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
- A61M25/10187—Indicators for the level of inflation or deflation
Definitions
- This invention relates generally to medical devices and methods of use, and more specifically, to materials, apparatus, and methods for facilitating hemostasis within a body cavity or passageway.
- Nasal passageways for example, are often susceptible to uncontrolled bleeding caused by various forms of trauma, disease or cellular dysfunction. Methods and devices for controlling, limiting or stopping such bleeding would be useful in a variety of situations, ranging from emergency room care to long term care.
- CMC carboxymethyl cellulose
- woven knit or matted fabrics thereof are known for use in the control of bleeding, such as post-trauma and post-surgical bleeding.
- CMC is defined as a polycarboxylmethyl ether of cellulose or the sodium salt thereof. It is sometimes referred to as cellulose ether, carboxymethylcellulose, or sodium caramellose. Insertion, application, and subsequent removal of these materials, however, can be difficult in small body passageways, such as nasal cavities.
- the present invention comprises methods and devices for the control of bleeding from an inner wall of a body passageway or cavity.
- the invention comprises an inflatable, expandable balloon, usually covered by a hemostatic shroud, which is inserted into a body cavity, such as a nasal passageway.
- the shroud is composed of a hemostatic agent; that is, the shroud acts to facilitate or enhance blood clot formation.
- the balloon component of the present invention is expanded, or inflated, within the cavity in order to press the shroud against the site of bleeding, thereby allowing it to absorb blood and facilitate hemostasis.
- the shroud is composed of a woven or knitted fabric of a hemostatic fiber (such as carboxymethylcellulose) or a reinforced hemostatic fiber.
- this shroud may include an “extension” or “tail” fiber, which upon balloon deflation and removal, facilitates the later removal of the shroud which has been intentionally left in vivo.
- the device construction may vary according to the particular body cavity. Although a range of different materials can be used for any of the embodiments, there are particular materials which work better than others, depending upon the particular application.
- one embodiment includes an inflatable balloon made from a relatively inelastic material.
- a particular embodiment of the invention comprises a device for insertion of a shrouded balloon into a nasal passageway by a catheter configured such that the balloon encircles the catheter tube.
- the lumen of the catheter tube thereby serves as a passageway for breathing.
- the inflated balloon compresses the shroud against the bleeding nasal wall, thereby facilitating or enhancing hemostasis.
- the balloon is deflatable such that, upon balloon deflation, the shroud may be left in place on the cavity wall and may be removed at a later time, such as by an attached extension on the shroud.
- the shroud used in the present invention may comprise a woven or knitted fabric combining hemostatic (e.g., carboxymethylcellulose (CMC)) fibers with reinforcing fibers.
- the shroud may be just a hemostatic agent disposed on the balloon in a film-like covering.
- FIG. 1 is a side view of a component adapted for insertion in a nasal passageway
- FIG. 2 is a side view of the component shown in FIG. 1 covered with a hemostatic shroud
- FIG. 3 a is a cross-sectional view of a device as shown in FIGS. 1 and 2;
- FIG. 3 b is a cross-sectional view of a device as shown in FIGS. 1 and 2;
- FIG. 4 is a schematic view of a knitted fabric structure useful in the present invention.
- FIG. 5 illustrates another embodiment of the invention which uses a pressure-indicating pilot balloon
- FIG. 6 illustrates a close-up, cross-sectional view of the inflatable balloon and shroud in accordance with the present invention
- FIG. 7 illustrates the same embodiment as illustrated in FIG. 5 with the pilot balloon deflated and turned 90°;
- FIG. 8 illustrates the same embodiment as illustrated in FIG. 7 but with the system inflated
- FIG. 9 is a partial cross-sectional view of a device according to one embodiment of the present invention using a clamp ring
- FIG. 10 is a partial cross-sectional view of the device of FIG. 9 having a balloon disposed between the central tube and the shroud;
- FIG. 11 is a side view of one embodiment of the present invention where the balloon is rolled around a central tube;
- FIG. 12 a is a cross-sectional view of the balloon rolled around the central tube
- FIG. 12 b is a cross-sectional view of the balloon unrolled and deflated around the central tube
- FIG. 12 c is a cross-sectional view of the balloon inflated around the central tube
- FIG. 13 is a cross-sectional view of the balloon rolled around the central tube, with a shroud disposed therearound in accordance with the present invention
- FIG. 14 is the cross-sectional view of FIG. 13 but with the system inflated;
- FIG. 15 is a side-view of the device shown in FIG. 11 but without the central tube;
- FIGS. 16 a - 16 e show the steps for forming a device in accordance with the present invention using a tube tool
- FIGS. 17 a and 17 b show a deflation hole in a central tube in accordance with one embodiment of the present invention
- FIG. 18 shows a side, partial cross-sectional view of a central tube without a deflation hole during deflation
- FIG. 19 is a cross-sectional view of the device with an inflation/deflation hole.
- FIG. 20 shows a device in accordance with the present invention where the inflation tube is not coaxial with a breathing lumen, and the inflation tube has an inflation/deflation hole.
- the present invention comprises systems, devices, and methods for the control of bleeding in body cavities, such as nasal passageways.
- body cavities such as nasal passageways.
- the terms “cavity” and “passageway” may include any bodily cavity, recess, passageway, etc., other than a blood vessel or other component of the vasculature system, and it encompasses those which are healthy and normal as well as those which are abnormal and/or pathological (meaning, diseased or unhealthy).
- the hemostatic agent may be a part of an expansible shroud or may make up the shroud itself.
- the hemostatic agent is either a film or fabric comprised of the hemostatic agent.
- the hemostatic agent is combined with another material, such as a reinforcing fiber material.
- the hemostatic agent-containing shroud covers an expansible device such as a balloon.
- the shroud may be in the form of an expandable tube or in the form of an expandable sheet.
- the preferred hemostatic agent is a fibrous CMC, which is hemostatic and so will cause blood to clot while at the same time absorbing any exudate.
- hemostatic agents which may be used should have absorptive and hemostatic properties similar to those of CMC.
- the hemostatic agent fibers are woven or knitted together with reinforcing fibers, such as continuous multifilament polyester or nylon.
- reinforcing fibers such as continuous multifilament polyester or nylon.
- FIG. 4 Such a knitted fabric is illustrated in FIG. 4, and is more fully described and claimed in separate patent applications (U.S. Ser. Nos. 09/406,490 filed Sep. 27, 1999, pending; and 09/612,038 filed Jul. 7, 2000, pending; both of which are incorporated by reference herein).
- the use of reinforcing fibers provides increased strength to the shroud. This increased strength is important for successful removal of a blood-soaked fabric, where the CMC or gellable material has formed a gel and therefore lost much of its strength.
- hemostatic materials examples include oxidized cellulose, which is conventionally used in knitted form as a hemostatic agent during surgery, and calcium alginate, which is a textile fiber derived from seaweed and is also commonly used as a wound dressing. Furthermore, there are other polysaccharides which are available with similar chemistry and properties to CMC. For purposes of the present invention, the essential properties of the hemostatic material are the ability to absorb large quantities of liquid without becoming enmeshed in the clotted blood. The material must be non-toxic and biocompatible.
- the shroud is provided in the form of a woven or knitted, especially a weft knitted, textile fabric in which is incorporated the hemostatic material, and which envelops the balloon.
- the woven or knitted textile material may be permanently or releasably fixed to the balloon.
- the balloon will be made of a relatively inelastic material, such as polyurethane or PVC.
- the balloon can be made from an elastomeric material, such as a thin silicone polymer.
- These balloons can be made by methods known to those skilled in the art, such as by dip molding.
- a fixed volume, inflatable, inelastic balloon does not require the inflating medium to first stretch the elastic material of the balloon (as would be the case where the balloon is made from an elastomeric material). All inflation medium pressure is used to fill the cavity. This is essential when the device is used with a pilot balloon to give a tactile feedback of the pressure inside the catheter balloon. With an inelastic, fixed volume balloon, the tactile feedback is truly representative of the pressure applied to the inner surface of the nasal cavity.
- an elastic material such as silicone rubber can be used for the balloon.
- a balloon may be inflated with a liquid medium such as water or saline solution and the volume controlled by monitoring the volume of fluid inserted.
- Silicone rubber has the property of being permeable to air but not to water or saline solution.
- a balloon catheter 50 consists of a soft flexible central tube 41 , with a long non-elastomeric balloon 48 adhered to the outside wall of central tube 41 along the end sections 49 of balloon 48 .
- the wall of central tube 41 includes an inflation lumen 51 (inflation passageway) which is in communication, through a thin tube 42 , with a valve and luer 43 at one end and an inflation port 52 at the other end.
- the valve 43 is opened by the tip of a standard syringe by which the balloon 48 may be inflated or deflated at will.
- Tube 41 includes a central breathing lumen 53 which serves as an air passage for breathing.
- central tube 41 has an approximate outside diameter of 10 mm, and an inside diameter of 4-5 mm.
- the active length is typically between 40 and 100 mm, although shorter or longer lengths may be required for special applications.
- One end of catheter 46 may have a reduction in the outer diameter in order to provide a shoulder 40 .
- This shoulder is used to locate and maintain the position of an outer hemostatic shroud, (seen in FIG. 2 and discussed in more detail below), during insertion of the device of FIG. 2 into a nasal passageway.
- the glued neck of the balloon supplies the shoulder and in yet another construction method no shoulder is used and the fabric is retained by a ring and glue or merely by glue alone.
- Catheter tube 41 typically is comprised of a silicone elastomer or PVC.
- the balloon is typically of fixed volume with an expanded diameter of approximately 25 mm and is expanded by inflation with air.
- FIG. 2 illustrates the balloon catheter component of FIG. 1 covered by a hemostatic shroud 44 which envelopes a portion of catheter tube 41 .
- Hemostatic shroud 44 can be a soft knitted or woven fabric tube made from a hemostatic material with a high absorption ability. The shroud material is discussed in more detail below.
- Shroud 44 is draped around the balloon catheter 50 and is positioned by a sewn ring or ligature 45 , which locates over shoulder 40 at the distal end 46 of the balloon catheter.
- the “ring over shoulder” mounting allows shroud 44 to be located precisely over balloon 48 when the device is inserted into the nasal cavity, but permits balloon 48 to be released from shroud 44 by simply withdrawing the catheter.
- shroud may also be used, such as a glued grommet, a welded ring, or by actually shaping the knitted shroud for retention on the balloon.
- the fabric shroud is highly elastic and deformable which allows it to stretch and/or deform as the balloon is inflated.
- An extension tail 47 to shroud 44 may be provided as a means to remove the hemostatic element separately after balloon 48 has been removed.
- FIG. 3 a shows a cross section, in the plane A-A, of nasal catheter 50 of FIG. 1 with hemostatic shroud 44 shown disposed thereon.
- balloon 48 is covered by hemostatic shroud 44 , encircling central tube 41 and the non-adhered underside thereof is in communication with inflation port 52 .
- balloon 48 is inflated by filling material, typically compressed air, from a syringe in communication with valve 43 and the inflation lumen 42 which terminates in port 52 at the inner surface of balloon 48 between the ends of the balloon which are adhered at tube surface areas 49 .
- material typically compressed air
- FIG. 4 illustrates a schematic view of a preferred fabric for the hemostatic shroud.
- spun CMC yarn 60 is knitted in parallel with a polyester reinforcing yarn 61 , as more specifically described in the aforementioned U.S. patent applications incorporated by reference.
- the knitted fabric tube is manufactured first by knitting a tube from Lyocell yarn in combination with the reinforcing filament.
- Lyocell is the generic name for solvent spun cellulose fiber. A brand thereof, “Tencel,” (a registered trademark), is available from Accordis Fibres, Coventry UK.
- Lyocell is produced from the natural cellulose in wood pulp by dissolving the wood pulp in a solvent and then extruding the product through a die called a spinneret. The solvent is then evaporated therefrom, thereby leaving a fiber which is composed of pure cellulose.
- the fabric tube is subjected to a sodium reactant, according to known techniques, which serves to convert the pure cellulose at least partially, into sodium carboxymethylcellulose.
- the chemical conversion process is similar to that used to make carboxymethylcellulose sodium USP, except that the raw cellulose is in fiber form rather than the more normal powder form.
- Other cellulosic raw materials can also be used such as cotton or viscose rayon.
- FIGS. 1 - 3 One use of the hemostatic nasal device of FIGS. 1 - 3 involves inserting into a nasal cavity the shroud-covered balloon catheter 50 illustrated in FIG. 2. Balloon 48 is then inflated. Because the shroud is deformable, it is able to expand and not limit the balloon in its ability to inflate and fill the cavity. The hemostatic fabric is pressed against the vessel wall and into contact with the blood. On contact with blood, the hemostatic shroud, typically CMC (or other similar material) is pressed against the cavity wall and swells to form a gel. It absorbs blood and exudate while its hemostatic properties facilitate and enhance blood clot formation. The lumen of the large (catheter) tube provides for normal breathing, while the inflated balloon provides an anchor for the device.
- CMC or other similar material
- the balloon 48 is deflated, and then the catheter is removed.
- the soft gel nature of the wet fabric shroud ensures that the device does not adhere to the clot.
- the balloon and tube only are removed and the gelled fabric is left in situ.
- the fabric may be removed at any later time by means of the withdrawal string or “tail” 47 . Since the hygroscopic nature of the hemostatic fabric prevents the material from sticking to the clotted blood, removal is simple and with minimal chance of restarting the bleeding process.
- the outer surface of the balloon itself is coated with an agent that facilitates blood coagulation.
- the shroud does not comprise a fabric of any kind, but is the hemostatic agent itself, provided in the form of a flexible film that coats the outer surface of the balloon.
- coating material include gelatin and collagen, but the invention is not limited to these.
- FIG. 3 b which is identical to FIG. 3 a except that the shroud 70 is comprised only of a film of hemostatic agent (no fabric).
- FIG. 3 a shows shroud 44 which is comprised, as described above, of a soft knitted or woven fabric made from a hemostatic material with a high absorption ability.
- the device of this invention may include a tactile pressure-indicating pilot balloon in fluid communication with the balloon by which pressure is exerted on the hemostatic shroud.
- both the shroud compressing balloon and the pilot balloon are expandable.
- both balloons are inflatable but made of a non-stretchable material.
- the “balloons” are really more like bags or plastic sacks which receive an inflation medium such as air.
- pilot balloon 190 may be disposed at the end of the inflation tube opposite the inflatable balloon of a nasal device as shown in FIG. 5.
- pilot balloon 190 is connected to first inflatable balloon 191 via inflation tube 195 .
- the external tactile pressure sensing pilot balloon 190 does not enter the passageway but allows the user to feel the pressure (usually by grasping the pilot between thumb and finger) within the system as the first inflatable balloon 191 is inflated.
- the pilot balloon 190 inflates along with inflatable balloon 190 during placement of hemostatic shroud 196 because the two balloons are in fluid communication with each other.
- the doctor is able to touch the pilot balloon and feel the pressure increase as the system inflates.
- this may be particularly important in nasal passageway applications, for example, because too little inflation pressure may result in a lack of blood flow stopage, and too great an inflation pressure may damage the passageway.
- too little inflation pressure may result in a lack of blood flow stopage, and too great an inflation pressure may damage the passageway.
- too little inflation pressure may result in a lack of blood flow stopage, and too great an inflation pressure may damage the passageway.
- too great an inflation pressure may damage the passageway.
- the first inflatable balloon (catheter balloon) be non-stretchable.
- the balloon is made of a relatively inelastic material (such as polyurethane or PVC) in order to have the ability of completely filling a cavity without any energy being used to stretch the wall of the balloon.
- the balloon is effectively a bag that can be filled or emptied with an inflation medium.
- the inflatable, non-stretchable balloon does not require the inflating medium to first stretch the elastic material of the balloon (as would be the case where the balloon is made from an elastomeric material). This is preferred when the device is used with a pilot balloon to give a tactile feedback of the pressure inside the catheter balloon. With a non-stretchable balloon, the tactile feedback is more representative of the pressure applied to the inner surface of the nasal cavity.
- the hemostatic shroud 196 is shown folded back over itself along the length of the inflation balloon 191 .
- half the fabric length is first placed over the balloon and the excess fabric is given a complete turn (or 360° twist) before inverting the twisted excess fabric over the balloon to give the second layer of fabric. This has the effect of closing the fabric over the distal end of the balloon as shown in FIG. 6.
- FIG. 7 illustrates the embodiment shown in FIG. 5 with pilot balloon 190 turned 90° from the view shown in FIG. 5.
- FIG. 6 is presented to illustrate the deflated pilot balloon which accompanies deflated inflatable balloon 191 .
- an inflation medium preferably air
- FIG. 8 This inflated pilot balloon 190 , as shown in FIG. 8, when touched or gripped by the doctor using the device, qualitatively indicates the pressure in the system.
- One such embodiment includes a soft tip to allow easier insertion into the nasal cavity as compared to a device not having a soft tip.
- the soft tip allows for less damage and irritation to the wall of the nasal cavity during insertion, particularly where the cavity does not exhibit smooth or straight walls.
- a soft tip can be formed on the distal end of a shaft which is configured to be inserted into a particular body cavity.
- central tube 230 is covered along its length by a suitable fabric 232 , such as a CMC fabric, or a knitted CMC-reinforcing filament fabric as described above.
- Fabric clamp ring 234 composed for example of medical grade PVC, is disposed longitudinally on the distal end 235 of central tube 230 and pinches fabric 232 to tube 230 .
- Clamp ring 234 is made from a length of very soft flexible tubing. It is not positioned completely onto tube 230 , however, but extends longitudinally beyond distal end 235 of tube 230 .
- a cylindrical piece of fabric 232 is slipped over central tube 230 and clamp ring 234 is slid over fabric 232 and part way on to central tube 230 . Then, fabric 232 is folded back, and inverted, around tube 230 to create a double layer of fabric along tube 230 . After fabric 232 is folded, a folded section 236 is created. This folded region 236 , draped over the very soft flexible clamp ring 234 , forms a soft tip which reduces trauma as the device is inserted into a body passageway.
- Film welding techniques are well known to those skilled in the art and are used in a variety of larger products such as blood bags, intravenous (IV) drug bags, pouches for card or badge protection, etc. Generally, the thinner the material, the better, so long as adequate strength is insured.
- the preferred thickness for the balloon thin film material is between 0.03 mm and 0.15 mm. The combination of this very thin walled balloon along with a thin inflation tube and thin fabric allows for a very small diameter device. The smaller the diameter, the easier the device can be inserted into a nasal passageway.
- balloon 240 is only secured to central tube 230 at its proximal end. This allows for the use of only one attachment means for the entire device, such as glue or a clamp ring 257 .
- the present invention also includes a method for manufacture of a device as represented in FIG. 6.
- This method involves the use of an assembly tool 260 as shown in FIG. 16 b.
- This tool is a relatively thin-walled cylinder and is made from a relatively rigid, or stiff, preferably transparent material.
- the method first requires the placement of shroud 232 over the balloon 240 and central tube 230 , as shown in FIG. 16 a.
- assembly tool 260 is pushed into shroud 232 , which shroud is simultaneously stretched around the outside surface of assembly tool 260 , as shown schematically in FIG. 16 b.
- FIG. 16 c illustrates the third step, which requires rotating assembly tool 260 , and shroud 232 along with it. The preferred rotation is 360°, although more rotation would achieve the same purpose.
- the next step is shown in FIG.
- Glue could also be used with this embodiment.
- a small amount of glue could be injected under the clamp ring at two spots, one each at 180° from the other around the circumference of the inflation tube where clamp ring 257 will be secured. Because the fabric is meshed, in the preferred embodiment, the glue will contact the fabric, the inflation tube, and the inside of the clamp ring, binding all three components together.
- a hole may be formed in the central tube wall as shown in FIGS. 17 a, 17 b, and 19 .
- hole 261 is formed so that inflation medium can enter and be withdrawn from a balloon surrounding the central tube 230 .
- the inflation medium can pass both at the distal and of the central tube 230 and laterally through hole 261 . This prevents a deflation limitation or stopage which could result at the distal end of central tube 230 , as shown in FIG. 18.
- FIG. 19 shows a cross-sectional view of central tube 230 having hole 261 with balloon 240 and shroud 232 disposed therearound.
- a hole 304 is provided along inflation lumen 300 .
- the hole could be formed from a number of different techniques.
- a preferred method of making the hole in this embodiment includes the use of a punch.
- the punch is a metal tube, with one end sharpened like a circular knife, which is inserted into the side of breathing tube 301 only far enough to create the hole 304 .
- the use of a punch instead of a conventionally drilled hole, helps insure that a conventional drill does not continue into the breathing passageway and open a hole there during manufacture of the device.
Abstract
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 09/927,864 filed Aug. 10, 2001, which in turn is a continuation-in-part of U.S. patent application Ser. No. 09/406,166 filed Sep. 27, 1999, which in turn is a continuation-in-part of U.S. patent application Ser. No. 09/057,414, filed on Apr. 8, 1998.
- This invention relates generally to medical devices and methods of use, and more specifically, to materials, apparatus, and methods for facilitating hemostasis within a body cavity or passageway.
- Nasal passageways, for example, are often susceptible to uncontrolled bleeding caused by various forms of trauma, disease or cellular dysfunction. Methods and devices for controlling, limiting or stopping such bleeding would be useful in a variety of situations, ranging from emergency room care to long term care.
- Bleeding is typical after nasal related surgeries or procedures, and epistaxis related to a patient's nasal passageway can be difficult to control. Hemostatic agents, such as carboxymethyl cellulose (CMC) and woven knit or matted fabrics thereof, are known for use in the control of bleeding, such as post-trauma and post-surgical bleeding. CMC is defined as a polycarboxylmethyl ether of cellulose or the sodium salt thereof. It is sometimes referred to as cellulose ether, carboxymethylcellulose, or sodium caramellose. Insertion, application, and subsequent removal of these materials, however, can be difficult in small body passageways, such as nasal cavities.
- The present invention comprises methods and devices for the control of bleeding from an inner wall of a body passageway or cavity. Briefly, the invention comprises an inflatable, expandable balloon, usually covered by a hemostatic shroud, which is inserted into a body cavity, such as a nasal passageway. The shroud is composed of a hemostatic agent; that is, the shroud acts to facilitate or enhance blood clot formation. The balloon component of the present invention is expanded, or inflated, within the cavity in order to press the shroud against the site of bleeding, thereby allowing it to absorb blood and facilitate hemostasis. In specific embodiments, the shroud is composed of a woven or knitted fabric of a hemostatic fiber (such as carboxymethylcellulose) or a reinforced hemostatic fiber. Optionally, this shroud may include an “extension” or “tail” fiber, which upon balloon deflation and removal, facilitates the later removal of the shroud which has been intentionally left in vivo.
- The device construction, particularly the balloon construction, may vary according to the particular body cavity. Although a range of different materials can be used for any of the embodiments, there are particular materials which work better than others, depending upon the particular application. For a nasal application, one embodiment includes an inflatable balloon made from a relatively inelastic material.
- A particular embodiment of the invention comprises a device for insertion of a shrouded balloon into a nasal passageway by a catheter configured such that the balloon encircles the catheter tube. The lumen of the catheter tube thereby serves as a passageway for breathing. The inflated balloon compresses the shroud against the bleeding nasal wall, thereby facilitating or enhancing hemostasis. The balloon is deflatable such that, upon balloon deflation, the shroud may be left in place on the cavity wall and may be removed at a later time, such as by an attached extension on the shroud.
- In another embodiment, there is no central lumen. This gives the catheter a much smaller overall diameter. In patients with small nasal cavities, the lack of the breathing passageway is more than compensated for by the small profile which is far less traumatic and painful during insertion.
- The shroud used in the present invention may comprise a woven or knitted fabric combining hemostatic (e.g., carboxymethylcellulose (CMC)) fibers with reinforcing fibers. Alternatively, the shroud may be just a hemostatic agent disposed on the balloon in a film-like covering.
- For a better understanding of the present invention, reference may be made to the detailed description which follows, taken in conjunction with the drawings, in which:
- FIG. 1 is a side view of a component adapted for insertion in a nasal passageway;
- FIG. 2 is a side view of the component shown in FIG. 1 covered with a hemostatic shroud;
- FIG. 3a is a cross-sectional view of a device as shown in FIGS. 1 and 2;
- FIG. 3b is a cross-sectional view of a device as shown in FIGS. 1 and 2;
- FIG. 4 is a schematic view of a knitted fabric structure useful in the present invention;
- FIG. 5 illustrates another embodiment of the invention which uses a pressure-indicating pilot balloon;
- FIG. 6 illustrates a close-up, cross-sectional view of the inflatable balloon and shroud in accordance with the present invention;
- FIG. 7 illustrates the same embodiment as illustrated in FIG. 5 with the pilot balloon deflated and turned 90°;
- FIG. 8 illustrates the same embodiment as illustrated in FIG. 7 but with the system inflated;
- FIG. 9 is a partial cross-sectional view of a device according to one embodiment of the present invention using a clamp ring;
- FIG. 10 is a partial cross-sectional view of the device of FIG. 9 having a balloon disposed between the central tube and the shroud;
- FIG. 11 is a side view of one embodiment of the present invention where the balloon is rolled around a central tube;
- FIG. 12a is a cross-sectional view of the balloon rolled around the central tube;
- FIG. 12b is a cross-sectional view of the balloon unrolled and deflated around the central tube;
- FIG. 12c is a cross-sectional view of the balloon inflated around the central tube;
- FIG. 13 is a cross-sectional view of the balloon rolled around the central tube, with a shroud disposed therearound in accordance with the present invention;
- FIG. 14 is the cross-sectional view of FIG. 13 but with the system inflated;
- FIG. 15 is a side-view of the device shown in FIG. 11 but without the central tube;
- FIGS. 16a-16 e show the steps for forming a device in accordance with the present invention using a tube tool;
- FIGS. 17a and 17 b show a deflation hole in a central tube in accordance with one embodiment of the present invention;
- FIG. 18 shows a side, partial cross-sectional view of a central tube without a deflation hole during deflation;
- FIG. 19 is a cross-sectional view of the device with an inflation/deflation hole; and
- FIG. 20 shows a device in accordance with the present invention where the inflation tube is not coaxial with a breathing lumen, and the inflation tube has an inflation/deflation hole.
- The present invention comprises systems, devices, and methods for the control of bleeding in body cavities, such as nasal passageways. Generally, the terms “cavity” and “passageway” may include any bodily cavity, recess, passageway, etc., other than a blood vessel or other component of the vasculature system, and it encompasses those which are healthy and normal as well as those which are abnormal and/or pathological (meaning, diseased or unhealthy).
- The term “hemostatic” agent (or material) refers to any agent or material that is capable of arresting, stemming, or preventing bleeding by means other than inducing tissue growth alone. In other words, something other than tissue growth is at least partially responsible for retarding or preventing bleeding. Preferably, the agent or material will be one that enhances blot clot formation. It will, of course, be appreciated that the agent or material may have the beneficial property of inducing tissue growth in addition to retarding or preventing bleeding. Examples of preferred hemostatic agents which enhance blood coagulation include carboxymethylcellulose (CMC), oxidized cellulose, calcium alginate, gelatine, or collagen. CMC can be purchased from Acordis Special Fibres, PO Box 111, 101 Lockhurst Land, Coventry, England, CV6 5RS. Oxidized cellulose such as Tabotamp™, which is sold by Johnson & Johnson, New Brunswick, N.J., U.S.A., is another example of a hemostatic agent. Combinations of different hemostatic agents or materials may be used within the scope of the invention.
- The hemostatic agent may be a part of an expansible shroud or may make up the shroud itself. In this later case, the hemostatic agent is either a film or fabric comprised of the hemostatic agent. In the former case, the hemostatic agent is combined with another material, such as a reinforcing fiber material. Typically, the hemostatic agent-containing shroud covers an expansible device such as a balloon. The shroud may be in the form of an expandable tube or in the form of an expandable sheet. In specific embodiments disclosed, the preferred hemostatic agent is a fibrous CMC, which is hemostatic and so will cause blood to clot while at the same time absorbing any exudate. A fabric of CMC fiber is preferred because, aside from its hemostatic properties, it swells and forms a gel, absorbing many times its own weight in fluid when it contacts water (or blood or exudate). Because the CMC material is so hygroscopic, it does not dry into the clotted blood, and therefore can be removed easily without tearing the clot and causing re-bleeding.
- Other hemostatic agents which may be used should have absorptive and hemostatic properties similar to those of CMC. In one embodiment, the hemostatic agent fibers are woven or knitted together with reinforcing fibers, such as continuous multifilament polyester or nylon. Such a knitted fabric is illustrated in FIG. 4, and is more fully described and claimed in separate patent applications (U.S. Ser. Nos. 09/406,490 filed Sep. 27, 1999, pending; and 09/612,038 filed Jul. 7, 2000, pending; both of which are incorporated by reference herein). The use of reinforcing fibers provides increased strength to the shroud. This increased strength is important for successful removal of a blood-soaked fabric, where the CMC or gellable material has formed a gel and therefore lost much of its strength.
- Examples of some other hemostatic materials include oxidized cellulose, which is conventionally used in knitted form as a hemostatic agent during surgery, and calcium alginate, which is a textile fiber derived from seaweed and is also commonly used as a wound dressing. Furthermore, there are other polysaccharides which are available with similar chemistry and properties to CMC. For purposes of the present invention, the essential properties of the hemostatic material are the ability to absorb large quantities of liquid without becoming enmeshed in the clotted blood. The material must be non-toxic and biocompatible.
- Preferably, the shroud is provided in the form of a woven or knitted, especially a weft knitted, textile fabric in which is incorporated the hemostatic material, and which envelops the balloon. The woven or knitted textile material may be permanently or releasably fixed to the balloon.
- In some embodiments, particularly those used in nasal applications, the balloon will be made of a relatively inelastic material, such as polyurethane or PVC. Alternatively, for other uses and embodiments, the balloon can be made from an elastomeric material, such as a thin silicone polymer. These balloons can be made by methods known to those skilled in the art, such as by dip molding. As noted above, it is generally desired in nasal applications that the balloon have a fixed volume and be made of an inelastic material. In such a case, the balloon is effectively a bag that can be filled or emptied with an inflation medium. A fixed volume, inflatable, inelastic balloon does not require the inflating medium to first stretch the elastic material of the balloon (as would be the case where the balloon is made from an elastomeric material). All inflation medium pressure is used to fill the cavity. This is essential when the device is used with a pilot balloon to give a tactile feedback of the pressure inside the catheter balloon. With an inelastic, fixed volume balloon, the tactile feedback is truly representative of the pressure applied to the inner surface of the nasal cavity.
- For particular non-nasal applications, an elastic material such as silicone rubber can be used for the balloon. Such a balloon may be inflated with a liquid medium such as water or saline solution and the volume controlled by monitoring the volume of fluid inserted. Silicone rubber has the property of being permeable to air but not to water or saline solution.
- One specific embodiment of the present invention which is designed for insertion within a nasal passageway is depicted in FIGS.1-3. As shown there, a
balloon catheter 50 consists of a soft flexiblecentral tube 41, with a longnon-elastomeric balloon 48 adhered to the outside wall ofcentral tube 41 along theend sections 49 ofballoon 48. The wall ofcentral tube 41 includes an inflation lumen 51 (inflation passageway) which is in communication, through athin tube 42, with a valve andluer 43 at one end and aninflation port 52 at the other end. Thevalve 43 is opened by the tip of a standard syringe by which theballoon 48 may be inflated or deflated at will.Tube 41 includes acentral breathing lumen 53 which serves as an air passage for breathing. - In a specific exemplary embodiment,
central tube 41 has an approximate outside diameter of 10 mm, and an inside diameter of 4-5 mm. The active length is typically between 40 and 100 mm, although shorter or longer lengths may be required for special applications. One end ofcatheter 46 may have a reduction in the outer diameter in order to provide ashoulder 40. This shoulder is used to locate and maintain the position of an outer hemostatic shroud, (seen in FIG. 2 and discussed in more detail below), during insertion of the device of FIG. 2 into a nasal passageway. In another method of construction the glued neck of the balloon supplies the shoulder and in yet another construction method no shoulder is used and the fabric is retained by a ring and glue or merely by glue alone.Catheter tube 41 typically is comprised of a silicone elastomer or PVC. In the embodiment of the present invention for use in a nasal passageway, the balloon is typically of fixed volume with an expanded diameter of approximately 25 mm and is expanded by inflation with air. - FIG. 2 illustrates the balloon catheter component of FIG. 1 covered by a
hemostatic shroud 44 which envelopes a portion ofcatheter tube 41.Hemostatic shroud 44 can be a soft knitted or woven fabric tube made from a hemostatic material with a high absorption ability. The shroud material is discussed in more detail below.Shroud 44 is draped around theballoon catheter 50 and is positioned by a sewn ring or ligature 45, which locates overshoulder 40 at thedistal end 46 of the balloon catheter. The “ring over shoulder” mounting allowsshroud 44 to be located precisely overballoon 48 when the device is inserted into the nasal cavity, but permitsballoon 48 to be released fromshroud 44 by simply withdrawing the catheter. Other methods of locating the shroud may also be used, such as a glued grommet, a welded ring, or by actually shaping the knitted shroud for retention on the balloon. The fabric shroud is highly elastic and deformable which allows it to stretch and/or deform as the balloon is inflated. Anextension tail 47 toshroud 44 may be provided as a means to remove the hemostatic element separately afterballoon 48 has been removed. - FIG. 3a shows a cross section, in the plane A-A, of
nasal catheter 50 of FIG. 1 withhemostatic shroud 44 shown disposed thereon. As shown in FIG. 3,balloon 48 is covered byhemostatic shroud 44, encirclingcentral tube 41 and the non-adhered underside thereof is in communication withinflation port 52. - In service,
balloon 48 is inflated by filling material, typically compressed air, from a syringe in communication withvalve 43 and theinflation lumen 42 which terminates inport 52 at the inner surface ofballoon 48 between the ends of the balloon which are adhered attube surface areas 49. - FIG. 4 illustrates a schematic view of a preferred fabric for the hemostatic shroud. Specifically, spun
CMC yarn 60 is knitted in parallel with apolyester reinforcing yarn 61, as more specifically described in the aforementioned U.S. patent applications incorporated by reference. In this preferred embodiment, the knitted fabric tube is manufactured first by knitting a tube from Lyocell yarn in combination with the reinforcing filament. Lyocell is the generic name for solvent spun cellulose fiber. A brand thereof, “Tencel,” (a registered trademark), is available from Accordis Fibres, Coventry UK. Lyocell is produced from the natural cellulose in wood pulp by dissolving the wood pulp in a solvent and then extruding the product through a die called a spinneret. The solvent is then evaporated therefrom, thereby leaving a fiber which is composed of pure cellulose. After knitting, the fabric tube is subjected to a sodium reactant, according to known techniques, which serves to convert the pure cellulose at least partially, into sodium carboxymethylcellulose. The chemical conversion process is similar to that used to make carboxymethylcellulose sodium USP, except that the raw cellulose is in fiber form rather than the more normal powder form. Other cellulosic raw materials can also be used such as cotton or viscose rayon. - One use of the hemostatic nasal device of FIGS.1-3 involves inserting into a nasal cavity the shroud-covered
balloon catheter 50 illustrated in FIG. 2.Balloon 48 is then inflated. Because the shroud is deformable, it is able to expand and not limit the balloon in its ability to inflate and fill the cavity. The hemostatic fabric is pressed against the vessel wall and into contact with the blood. On contact with blood, the hemostatic shroud, typically CMC (or other similar material) is pressed against the cavity wall and swells to form a gel. It absorbs blood and exudate while its hemostatic properties facilitate and enhance blood clot formation. The lumen of the large (catheter) tube provides for normal breathing, while the inflated balloon provides an anchor for the device. After hemostasis is achieved, theballoon 48 is deflated, and then the catheter is removed. The soft gel nature of the wet fabric shroud ensures that the device does not adhere to the clot. In one embodiment the balloon and tube only are removed and the gelled fabric is left in situ. - Where the gelled fabric alone has been left in situ, the fabric may be removed at any later time by means of the withdrawal string or “tail”47. Since the hygroscopic nature of the hemostatic fabric prevents the material from sticking to the clotted blood, removal is simple and with minimal chance of restarting the bleeding process.
- In an alternative embodiment, the outer surface of the balloon itself is coated with an agent that facilitates blood coagulation. In such an embodiment, the shroud does not comprise a fabric of any kind, but is the hemostatic agent itself, provided in the form of a flexible film that coats the outer surface of the balloon. Examples of coating material include gelatin and collagen, but the invention is not limited to these. Such an embodiment is shown in FIG. 3b, which is identical to FIG. 3a except that the
shroud 70 is comprised only of a film of hemostatic agent (no fabric). In slight distinction, FIG. 3a showsshroud 44 which is comprised, as described above, of a soft knitted or woven fabric made from a hemostatic material with a high absorption ability. - Pilot Balloon Tactile Pressure Indicator
- In another embodiment, the device of this invention may include a tactile pressure-indicating pilot balloon in fluid communication with the balloon by which pressure is exerted on the hemostatic shroud. In such an embodiment, both the shroud compressing balloon and the pilot balloon are expandable. Preferably, both balloons are inflatable but made of a non-stretchable material. In this embodiment, the “balloons” are really more like bags or plastic sacks which receive an inflation medium such as air. Once the balloon is fully inflated, its volume no longer changes because the material of which it is made does not stretch. In use the balloon will typically not be inflated to its maximum volume because the cavity into which the balloon is inflated will preferably be smaller than the theoretical maximum volume of the balloon. This is because the maximum volume and dimensions of the balloon are typically chosen to be larger than the cavity in order that the balloon always has the capacity to fill the cavity. In this way, the hemostatic shroud, which surrounds the balloon, is pressed against the complete inner surface of the cavity.
- Such a pilot balloon may be disposed at the end of the inflation tube opposite the inflatable balloon of a nasal device as shown in FIG. 5. In this embodiment,
pilot balloon 190 is connected to firstinflatable balloon 191 viainflation tube 195. Thus, the external tactile pressure sensingpilot balloon 190 does not enter the passageway but allows the user to feel the pressure (usually by grasping the pilot between thumb and finger) within the system as the firstinflatable balloon 191 is inflated. In this embodiment, thepilot balloon 190 inflates along withinflatable balloon 190 during placement ofhemostatic shroud 196 because the two balloons are in fluid communication with each other. Thus, during placement, the doctor is able to touch the pilot balloon and feel the pressure increase as the system inflates. As discussed above, this may be particularly important in nasal passageway applications, for example, because too little inflation pressure may result in a lack of blood flow stopage, and too great an inflation pressure may damage the passageway. Thus, through a careful tactile determination of system pressure during inflation and placement of the hemostatic fabric, proper and effective use of the device is insured. - In order for the tactile pressure sensing pilot balloon to give a more accurate indication of the pressure inside the nasal cavity, it is preferred that the first inflatable balloon (catheter balloon) be non-stretchable. In accordance with this aspect of the invention, the balloon is made of a relatively inelastic material (such as polyurethane or PVC) in order to have the ability of completely filling a cavity without any energy being used to stretch the wall of the balloon. In such a case, the balloon is effectively a bag that can be filled or emptied with an inflation medium. The inflatable, non-stretchable balloon does not require the inflating medium to first stretch the elastic material of the balloon (as would be the case where the balloon is made from an elastomeric material). This is preferred when the device is used with a pilot balloon to give a tactile feedback of the pressure inside the catheter balloon. With a non-stretchable balloon, the tactile feedback is more representative of the pressure applied to the inner surface of the nasal cavity.
- FIG. 5 also illustrates
hemostatic shroud 196 disposed on firstinflatable balloon 191. As discussed above, various means for introducing air or other suitable pressurizing fluid into the system can be used. FIG. 5 shows aLuer slip valve 197 attached to one end of apilot balloon 190 the opposite end of which is connected viainflation tube 195. Such slip valves are known to those skilled in the art to provide the introduction of an inflating medium, typically air, into the system. Also shown in FIG. 5 isfabric clamp ring 198 used to hold thehemostatic shroud 196 to the inflation tube and/or base ofinflatable balloon 191. In this embodiment, which includes no central tube,inflation tube 195 ends whereinflatable balloon 191 andinflation tube 195 connect atclamp ring 198. In the alternative embodiment shown in FIG. 6, aninflation tube 200 actually extends intoinflatable balloon 191. - FIG. 6 illustrates a close-up, partially cross sectional view of
inflation balloon 191 withinhemostatic shroud 196. Withininflation balloon 191 isinternal inflation tube 200.Internal inflation tube 200 as shown in FIG. 6 is either an integral extension of aninflation tube 195 as seen in FIG. 5, or is a separate piece of tubing in fluid communication with aninflation tube 195 as seen in FIG. 5.Internal inflation tube 200 is shown as open at itsend 205 in FIG. 6. - In FIG. 6, the
hemostatic shroud 196 is shown folded back over itself along the length of theinflation balloon 191. In assembling theshroud 196 over theballoon 191, half the fabric length is first placed over the balloon and the excess fabric is given a complete turn (or 360° twist) before inverting the twisted excess fabric over the balloon to give the second layer of fabric. This has the effect of closing the fabric over the distal end of the balloon as shown in FIG. 6. - FIG. 7 illustrates the embodiment shown in FIG. 5 with
pilot balloon 190 turned 90° from the view shown in FIG. 5. FIG. 6 is presented to illustrate the deflated pilot balloon which accompanies deflatedinflatable balloon 191. After an inflation medium (preferably air ) is introduced into the system, the resultant configuration ofpilot balloon 190 is shown in FIG. 8. Thisinflated pilot balloon 190, as shown in FIG. 8, when touched or gripped by the doctor using the device, qualitatively indicates the pressure in the system. - In one embodiment, the pilot balloon as illustrated in FIGS.5-8, has a wall thickness of about 0.09 mm (0.0035 inches) and is comprised of polyvinyl chloride (PVC). Typically, the pilot balloon is approximately 0.5 to 2 inches in length.
- In its nasal embodiments, the method comprises the steps of inserting into a nasal cavity a first inflatable balloon surrounded at least in part by a hemostatic shroud comprising a gel-forming absorbent composition. The inflatable balloon is then expanded which compresses the shroud against the inner surface of the cavity where bleeding is to be controlled. Where the device includes a pilot balloon, the pressure inside the inflatable balloon is monitored, during expansion of the inflatable balloon and shroud, by touching the pressure-indicating pilot balloon which is in fluid communication with the first inflatable balloon.
- Nasal Applications
- Soft Tip
- When it is desired to use the present invention in a narrow body cavity, such as in a nasal application, several embodiments are particularly advantageous. One such embodiment includes a soft tip to allow easier insertion into the nasal cavity as compared to a device not having a soft tip. The soft tip allows for less damage and irritation to the wall of the nasal cavity during insertion, particularly where the cavity does not exhibit smooth or straight walls. For this purpose, a soft tip can be formed on the distal end of a shaft which is configured to be inserted into a particular body cavity.
- In one such soft-tip embodiment, shown in FIG. 9,
central tube 230 is covered along its length by asuitable fabric 232, such as a CMC fabric, or a knitted CMC-reinforcing filament fabric as described above.Fabric clamp ring 234, composed for example of medical grade PVC, is disposed longitudinally on thedistal end 235 ofcentral tube 230 and pinchesfabric 232 totube 230.Clamp ring 234 is made from a length of very soft flexible tubing. It is not positioned completely ontotube 230, however, but extends longitudinally beyonddistal end 235 oftube 230. - During manufacture of this embodiment, a cylindrical piece of
fabric 232 is slipped overcentral tube 230 andclamp ring 234 is slid overfabric 232 and part way on tocentral tube 230. Then,fabric 232 is folded back, and inverted, aroundtube 230 to create a double layer of fabric alongtube 230. Afterfabric 232 is folded, a foldedsection 236 is created. This foldedregion 236, draped over the very softflexible clamp ring 234, forms a soft tip which reduces trauma as the device is inserted into a body passageway. - In one embodiment, glue can be used to set
clamp ring 234 into place. The glue would be placed betweenfabric 232 andtube 230 where the clamp ring overlapstube 230. A preferred glue is a cyanoacrylate based glue, a more preferred glue being Loctite 4011. Loctite is a registered trademark of Loctite Corporation. - FIG. 10 shows the embodiment of FIG. 9 but with a
balloon 240 disposed betweenshroud 232 andcentral tube 230.Balloon 240 is attached toward the distal end ofcentral tube 230 by any of a number of means, including the use of glue or heat sealing the balloon directly tocentral tube 230 at itsdistal end 241. Means for inflatingballoon 240 are not shown in FIG. 10, but are addressed in other parts of this specification. - A second way to achieve the soft tip of the invention is used on the version which does not include a central airway or breathing tube. This involves rolling the balloon around the central tube or rolling the balloon around itself underneath the fabric (See FIG. 15). In the former embodiment, a thin-walled balloon is disposed on a central tube and, when deflated, is flattened and rolled around the tube around the same longitudinal axis defined by the central tube, similar to how a roll of paper towels are disposed around a cardboard tube. FIG. 11 shows such an embodiment where
balloon 240 is rolled aroundcentral tube 230.Balloon 240 is sized so as to extend beyond the distal end ofcentral tube 230. The region ofextension 245 provides a soft tip for the device which achieves the above described advantages during placement. Preferably, the balloon is made from a film welding technique to achieve a very thin walled balloon. Typical materials for the balloon include PVC and polyurethane. Any suitable polymer would work, so long as it is easily welded and maintains adequate strength to allow expansion of an inflation medium without breaking. - Film welding techniques (including radio frequency welding) are well known to those skilled in the art and are used in a variety of larger products such as blood bags, intravenous (IV) drug bags, pouches for card or badge protection, etc. Generally, the thinner the material, the better, so long as adequate strength is insured. The preferred thickness for the balloon thin film material is between 0.03 mm and 0.15 mm. The combination of this very thin walled balloon along with a thin inflation tube and thin fabric allows for a very small diameter device. The smaller the diameter, the easier the device can be inserted into a nasal passageway.
- FIGS. 12a-12 c show three cross sections of
balloon 240 andcentral tube 230. FIG. 12a shows the balloon rolled aroundcentral tube 230. FIG. 12b shows theballoon 240 unrolled but not fully inflated aroundcentral tube 230, and FIG. 12c shows theballoon 240 inflated aroundcentral tube 230. FIG. 13 shows the cross section of FIG. 12a withshroud 232 shown disposed around theballoon 240. Whencentral tube 230 receives inflation medium (typically air), the medium passes through a passageway, typically a hole (not shown) in the wall oftube 230 and into the interior ofballoon 240.Balloon 240 then expands and unrolls withinshroud 232 and expands to causeshroud 232 to contact the inner surface of the body passageway or cavity where bleeding is to be controlled. FIG. 14 showsballoon 240 expanded withinshroud 232. FIGS. 13 and 14 show theshroud 232 as a two layer shroud, consistent with the embodiment shown in FIG. 10. The shroud could, however, be single layered or have more than two layers. - The balloon rolling does not have to be rolled around a central tube. As described above, no central tube is present in some embodiments. In such a case, the fabric would be disposed around a rolled balloon where the balloon is simply rolled up on itself. An example of this later embodiment is shown in FIG. 15. A tubular connection for introducing inflation media would obviously be included. A forceps or other instrument may be required to deploy such an embodiment.
- Twisted Fabric Construction
- In another embodiment, the shroud is attached to the inflation lumen at only the proximal end of the device, as shown in FIGS. 6 and 16e. Here,
shroud 232 is doubled-up, back over itself along the length ofcentral tube 230. In this embodiment, however, and unlike the embodiment shown in FIG. 9, the assembly ofshroud 232 overballoon 240 involves the twisting of the fabric at its distal end. Here, half the fabric length is first placed over the balloon and the excess fabric is turned, preferably in a complete turn (or 360° twist) at its distal end before inverting the twisted excess shroud back over the balloon and first layer of shroud to provide the second layer of shroud. This has the effect of closing the shroud over the distal end of the balloon as shown in FIG. 6. In such an embodiment,balloon 240 is only secured tocentral tube 230 at its proximal end. This allows for the use of only one attachment means for the entire device, such as glue or aclamp ring 257. - The present invention also includes a method for manufacture of a device as represented in FIG. 6. This method, as shown in FIGS. 16a-16 e, involves the use of an
assembly tool 260 as shown in FIG. 16b. This tool is a relatively thin-walled cylinder and is made from a relatively rigid, or stiff, preferably transparent material. - The method first requires the placement of
shroud 232 over theballoon 240 andcentral tube 230, as shown in FIG. 16a. In the next step,assembly tool 260 is pushed intoshroud 232, which shroud is simultaneously stretched around the outside surface ofassembly tool 260, as shown schematically in FIG. 16b. FIG. 16c illustrates the third step, which requiresrotating assembly tool 260, andshroud 232 along with it. The preferred rotation is 360°, although more rotation would achieve the same purpose. The next step is shown in FIG. 16d, which illustrates the progression ofassembly tool 260 toward the proximal end of the device, which causesshroud 232 to double over on itself, forming a double layer of fabric along the outside surface ofballoon 240. FIG. 16e shows the result of this method, after aclamp ring 257 is placed aroundshroud 232 at the proximal end of the device, thereby securing the fabric in place. Any excess fabric that would extend beyond theclamp ring 257 could then be trimmed from the device. - Glue could also be used with this embodiment. During the step of placing
clamp ring 257, a small amount of glue could be injected under the clamp ring at two spots, one each at 180° from the other around the circumference of the inflation tube whereclamp ring 257 will be secured. Because the fabric is meshed, in the preferred embodiment, the glue will contact the fabric, the inflation tube, and the inside of the clamp ring, binding all three components together. - This method can also be used to place fabric around a device which has no central inflation lumen, but which has only an inflation balloon attached to the distal end of the inflation tube. Such an embodiment is shown in FIG. 5. In such a case, only the balloon and fabric extend beyond the distal end of the inflation tube.
- In some embodiments of the invention, particularly those not including a breathing lumen, there is a risk that upon deflation, the balloon and/or surrounding fabric will be sucked into the passageway by which inflation medium passes from the central tube into the balloon. This is illustrated in FIG. 18, wherein
balloon 240 is shown sucked into a blocking position atdistal end 275 ofcentral tube 230. This may result in preventing complete deflation ofballoon 240. - To prevent this potential problem, a hole may be formed in the central tube wall as shown in FIGS. 17a, 17 b, and 19. As shown in FIGS. 17a and 17 b,
hole 261 is formed so that inflation medium can enter and be withdrawn from a balloon surrounding thecentral tube 230. The inflation medium can pass both at the distal and of thecentral tube 230 and laterally throughhole 261. This prevents a deflation limitation or stopage which could result at the distal end ofcentral tube 230, as shown in FIG. 18. FIG. 19 shows a cross-sectional view ofcentral tube 230 havinghole 261 withballoon 240 andshroud 232 disposed therearound. - FIG. 20 illustrates an embodiment having a
breathing tube 301 whereinflation lumen 300 is disposed within the wall of breathingtube 301. In this embodiment, balloon 302 is shown disposed around breathingtube 301, andinflation lumen 300 is disposed radially offset from the central axis ofbreathing tube 301. Here,inflation lumen 300 extends along the entire length ofbreathing tube 301, and is blocked at its distal end byglue 303. Alternatively,inflation lumen 300 could be formed so as not to continue all the way to the end of the breathing tube 301 (as shown in FIG. 1). The important aspect ofinflation lumen 300 is that it not be open at the breathing tube's distal end. - To allow delivery of inflation medium to balloon302, a
hole 304 is provided alonginflation lumen 300. The hole could be formed from a number of different techniques. A preferred method of making the hole in this embodiment includes the use of a punch. The punch is a metal tube, with one end sharpened like a circular knife, which is inserted into the side ofbreathing tube 301 only far enough to create thehole 304. The use of a punch, instead of a conventionally drilled hole, helps insure that a conventional drill does not continue into the breathing passageway and open a hole there during manufacture of the device. - An additional advantage to using the punch, instead of a conventional drill, is that, unlike a conventional drill, the punch cuts a clean hole and does not create loose material or shavings which could be difficult to remove from the device and could cause a contamination hazard during later use of the device. By using the punch, the punched material is removed within the shaft of the punch and discarded.
- The foregoing comprises a description of certain exemplary embodiments of the present invention. The invention is not limited to these embodiments, however, and the subjoined claims are intended to be construed to encompass all embodiments of this invention, and equivalents and variants thereof, which may be made by those skilled in the art without departing from the true spirit and scope of the essential concepts disclosed and claimed herein.
Claims (27)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/998,524 US7018392B2 (en) | 1998-04-08 | 2001-11-28 | Hemostatic system for body cavities |
US11/364,965 US20060271094A1 (en) | 1998-04-08 | 2006-02-28 | Hemostatic system for body cavities |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5741498A | 1998-04-08 | 1998-04-08 | |
US09/406,166 US6306154B1 (en) | 1997-06-18 | 1999-09-27 | Hemostatic system for body cavities |
US09/927,864 US6706051B2 (en) | 1998-04-08 | 2001-08-10 | Hemostatic system for body cavities |
US09/998,524 US7018392B2 (en) | 1998-04-08 | 2001-11-28 | Hemostatic system for body cavities |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/927,864 Continuation-In-Part US6706051B2 (en) | 1998-04-08 | 2001-08-10 | Hemostatic system for body cavities |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/364,965 Continuation US20060271094A1 (en) | 1998-04-08 | 2006-02-28 | Hemostatic system for body cavities |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020077653A1 true US20020077653A1 (en) | 2002-06-20 |
US7018392B2 US7018392B2 (en) | 2006-03-28 |
Family
ID=46278516
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/998,524 Expired - Lifetime US7018392B2 (en) | 1998-04-08 | 2001-11-28 | Hemostatic system for body cavities |
US11/364,965 Abandoned US20060271094A1 (en) | 1998-04-08 | 2006-02-28 | Hemostatic system for body cavities |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/364,965 Abandoned US20060271094A1 (en) | 1998-04-08 | 2006-02-28 | Hemostatic system for body cavities |
Country Status (1)
Country | Link |
---|---|
US (2) | US7018392B2 (en) |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030120134A1 (en) * | 2001-11-02 | 2003-06-26 | Rao R. Bharat | Patient data mining for cardiology screening |
US20050019262A1 (en) * | 2003-07-25 | 2005-01-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20050058721A1 (en) * | 2003-09-12 | 2005-03-17 | Hursey Francis X. | Partially hydrated hemostatic agent |
US20050114613A1 (en) * | 2003-10-30 | 2005-05-26 | Takayuki Otani | Multi-chip package type memory system |
US20050124937A1 (en) * | 2003-12-05 | 2005-06-09 | Kick George F. | Expandable percutaneous sheath |
US20050125021A1 (en) * | 2003-12-05 | 2005-06-09 | Nance Edward J. | Expandable percutaneous sheath |
EP1626766A2 (en) * | 2003-05-28 | 2006-02-22 | Rose Biomedical Development Corporation | Inflatable nasal packing device with two non-elastic, flexible bags oversized relative to nasal cavities |
US20060079727A1 (en) * | 2004-09-03 | 2006-04-13 | Rubicor Medical, Inc. | Short term post surgical cavity treatment devices and methods |
US20060085022A1 (en) * | 2004-10-15 | 2006-04-20 | Kelli Hayes | Non-compliant medical balloon having an integral woven fabric layer |
US20060085023A1 (en) * | 2004-10-15 | 2006-04-20 | Davies William F Jr | Medical balloon having strengthening rods |
US20060135981A1 (en) * | 2004-09-09 | 2006-06-22 | Jay Lenker | Expandable transluminal sheath |
US20060135962A1 (en) * | 2004-09-09 | 2006-06-22 | Kick George F | Expandable trans-septal sheath |
US20060271094A1 (en) * | 1998-04-08 | 2006-11-30 | Arthrocare Corporation | Hemostatic system for body cavities |
US20070016133A1 (en) * | 2005-07-05 | 2007-01-18 | Futurematrix Interventional, Inc. | Rapid exchange balloon dilation catheter having reinforced multi-lumen distal portion |
US20070135711A1 (en) * | 2003-07-25 | 2007-06-14 | Rubicor Medical, Inc. | Methods and systems for marking post biopsy cavity sites |
US20070167971A1 (en) * | 2006-01-17 | 2007-07-19 | Raymond Huey | Devices and methods for promoting the formation of blood clots in esophageal varices |
US20070219490A1 (en) * | 2004-10-15 | 2007-09-20 | Futuremed Interventional, Inc. | Non-compliant medical balloon having an integral non-woven fabric layer |
US20070251849A1 (en) * | 2006-04-27 | 2007-11-01 | Denny Lo | Devices for the identification of medical products |
US20070275073A1 (en) * | 2006-05-26 | 2007-11-29 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US20070299339A1 (en) * | 2003-07-25 | 2007-12-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20080317831A1 (en) * | 2007-06-21 | 2008-12-25 | Denny Lo | Hemostatic sponge and method of making the same |
US20090149700A1 (en) * | 2007-11-02 | 2009-06-11 | Ruben Garcia | Method and apparatus for pubic sling insertion |
US20090162406A1 (en) * | 2007-09-05 | 2009-06-25 | Z-Medica Corporation | Wound healing with zeolite-based hemostatic devices |
US20090171277A1 (en) * | 2005-06-22 | 2009-07-02 | Futurematrix Interventional, Inc. | Balloon dilation catheter having transition from coaxial lumens to non-coaxial multiple lumens |
US20090209969A1 (en) * | 2005-03-02 | 2009-08-20 | C.R. Bard Inc | Expandable access sheath |
US20090287182A1 (en) * | 2008-05-14 | 2009-11-19 | Onset Medical Corporation | Expandable iliac sheath and method of use |
US20100121244A1 (en) * | 2005-02-09 | 2010-05-13 | Z-Medica Corporation | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
US7722568B2 (en) | 2007-01-29 | 2010-05-25 | Onset Medical Corporation | Expandable intra-aortic balloon pump sheath |
US20100145267A1 (en) * | 2008-11-10 | 2010-06-10 | Onset Medical Corporation | Expandable spinal sheath and method of use |
US20100228174A1 (en) * | 2006-05-26 | 2010-09-09 | Huey Raymond J | Clay-based hemostatic agents and devices for the delivery thereof |
US20100233248A1 (en) * | 2006-05-26 | 2010-09-16 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US7892203B2 (en) | 2004-09-09 | 2011-02-22 | Onset Medical Corporation | Expandable transluminal sheath |
US7914487B2 (en) | 2004-10-15 | 2011-03-29 | Futurematrix Interventional, Inc. | Non-compliant medical balloon having braided or knitted reinforcement |
US20110144690A1 (en) * | 2008-05-14 | 2011-06-16 | Onset Medical Corporation | Expandable transapical sheath and method of use |
US8002744B2 (en) | 2007-08-06 | 2011-08-23 | Bard Peripheral Vascular, Inc | Non-compliant medical balloon |
US20120071913A1 (en) * | 2010-09-21 | 2012-03-22 | Tamez Oscar A | Nasal splints |
US8313601B2 (en) | 2007-08-06 | 2012-11-20 | Bard Peripheral Vascular, Inc. | Non-compliant medical balloon |
US8337518B2 (en) | 2006-12-20 | 2012-12-25 | Onset Medical Corporation | Expandable trans-septal sheath |
US8562559B2 (en) | 2008-05-14 | 2013-10-22 | Onset Medical Corporation | Expandable iliac sheath and method of use |
US8597240B2 (en) | 2011-02-02 | 2013-12-03 | Futurematrix Interventional, Inc. | Coaxial catheter shaft having balloon attachment feature with axial fluid path |
US8728110B2 (en) | 2009-01-16 | 2014-05-20 | Bard Peripheral Vascular, Inc. | Balloon dilation catheter shaft having end transition |
US8814899B2 (en) | 2009-02-23 | 2014-08-26 | Futurematrix Interventional, Inc. | Balloon catheter pressure relief valve |
US8858969B2 (en) | 2010-09-22 | 2014-10-14 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
US8900214B2 (en) | 2007-03-30 | 2014-12-02 | Onset Medical Corporation | Expandable trans-septal sheath |
US20150073487A1 (en) * | 2013-09-09 | 2015-03-12 | Globus Medical, Inc. | Percutaneous bone screw device and method |
US9072806B2 (en) | 2012-06-22 | 2015-07-07 | Z-Medica, Llc | Hemostatic devices |
US9211391B2 (en) | 2009-09-24 | 2015-12-15 | Bard Peripheral Vascular, Inc. | Balloon with variable pitch reinforcing fibers |
US9259559B2 (en) | 2009-02-23 | 2016-02-16 | Futurematrix Interventional, Inc. | Balloon catheter pressure relief valve |
US9821084B2 (en) | 2005-02-15 | 2017-11-21 | Virginia Commonwealth University | Hemostasis of wound having high pressure blood flow using kaolin and bentonite |
US10188838B2 (en) | 2009-08-24 | 2019-01-29 | Cook Medical Technologies Llc | Textile-reinforced high-pressure balloon |
US10806476B2 (en) | 2017-11-12 | 2020-10-20 | David Awrey Randall | Anterior—posterior inflatable nosebleed packing |
KR20220011917A (en) * | 2020-07-22 | 2022-02-03 | 서울대학교병원 | self epistaxis control device |
US11596423B2 (en) | 2018-06-21 | 2023-03-07 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0011052D0 (en) * | 2000-05-09 | 2000-06-28 | Hudson John O | Medical device and use thereof |
GB0011053D0 (en) | 2000-05-09 | 2000-06-28 | Hudson John O | Medical device and use thereof |
GB0030794D0 (en) * | 2000-12-16 | 2001-01-31 | Hudson John O | Medical device and use thereof |
WO2005027808A1 (en) | 2003-09-12 | 2005-03-31 | Z-Medica Corporation | Calcium zeolite hemostatic agent |
GB2409162B (en) * | 2004-10-06 | 2005-12-14 | Bhk Holding Ltd | Materials,methods,and apparatus for treating a body cavity |
JP4833988B2 (en) | 2004-10-08 | 2011-12-07 | タイコ ヘルスケア グループ リミテッド パートナーシップ | Endoscopic surgical clip applier |
US7819886B2 (en) | 2004-10-08 | 2010-10-26 | Tyco Healthcare Group Lp | Endoscopic surgical clip applier |
GB0502546D0 (en) * | 2005-02-08 | 2005-03-16 | Varma Rajiv | Ellis disimpacter |
US9326995B2 (en) | 2005-04-04 | 2016-05-03 | The Regents Of The University Of California | Oxides for wound healing and body repair |
US20060282046A1 (en) * | 2005-04-13 | 2006-12-14 | Horn Jeffrey L | Device and method for subcutaneous delivery of blood clotting agent |
US20070042326A1 (en) * | 2005-06-01 | 2007-02-22 | Osseous Technologies Of America | Collagen antral membrane expander |
US7717312B2 (en) | 2005-06-03 | 2010-05-18 | Tyco Healthcare Group Lp | Surgical instruments employing sensors |
US20070142783A1 (en) * | 2005-12-16 | 2007-06-21 | Huey Raymond J | Devices and methods for promoting the formation of blood clots at dialysis access sites |
US20070276308A1 (en) * | 2006-05-26 | 2007-11-29 | Huey Raymond J | Hemostatic agents and devices for the delivery thereof |
AU2008216866B2 (en) * | 2007-02-09 | 2014-03-20 | B & D Medical Development, Llc | Pelvic balloon tamponade |
US20080249506A1 (en) * | 2007-04-06 | 2008-10-09 | David Neustaedter | Methods of treating diverticula |
US8361100B2 (en) | 2008-03-17 | 2013-01-29 | Ethicon, Inc. | Applicator instruments for the delivery, deployment, and tamponade of hemostats and methods therefor |
US8366733B2 (en) * | 2008-03-28 | 2013-02-05 | Ethicon, Inc. | Applicator instruments for controlling bleeding at surgical sites and methods therefor |
US8113405B2 (en) * | 2008-09-03 | 2012-02-14 | Tyco Healthcare Group, Lp | Surgical instrument with indicator |
US8770460B2 (en) * | 2008-12-23 | 2014-07-08 | George E. Belzer | Shield for surgical stapler and method of use |
US8205779B2 (en) * | 2009-07-23 | 2012-06-26 | Tyco Healthcare Group Lp | Surgical stapler with tactile feedback system |
US8955732B2 (en) | 2009-08-11 | 2015-02-17 | Covidien Lp | Surgical stapling apparatus |
US8360299B2 (en) * | 2009-08-11 | 2013-01-29 | Covidien Lp | Surgical stapling apparatus |
US8276801B2 (en) | 2011-02-01 | 2012-10-02 | Tyco Healthcare Group Lp | Surgical stapling apparatus |
RU2018136593A (en) | 2016-03-18 | 2020-04-20 | Просепт Байороботикс Корпорейшн | MINIMALLY INVASIVE METHODS AND SYSTEMS FOR HEMOSTASIS IN THE BLOODING BLOOD CLOSED TISSUE |
US11559670B2 (en) | 2017-05-23 | 2023-01-24 | Ortho-Space Ltd. | Bladder rolling machine |
GB2568489B (en) | 2017-11-16 | 2022-07-13 | Safe Obstetric Systems Ltd | A fetus delivery assisting device |
CN112641489A (en) * | 2020-12-31 | 2021-04-13 | 华中科技大学 | Nasal cavity filling balloon for nasal septum orthopaedy and manufacturing method and system thereof |
CN113100862B (en) * | 2021-04-08 | 2022-11-08 | 苏坤雄 | Lying device with pressing hemostasis function |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3483859A (en) * | 1967-11-29 | 1969-12-16 | Fred E Pittman | String for marking bleeding in upper gastro-intestinal tract |
US3618607A (en) * | 1970-02-17 | 1971-11-09 | Johnson & Johnson | Saline fluid absorption and retention tampons and methods of making the same |
US4041948A (en) * | 1976-07-26 | 1977-08-16 | Johnson & Johnson | Digital tampon |
US5263966A (en) * | 1991-11-29 | 1993-11-23 | Yousef Daneshvar | Device for suppressing post-catheterization wound bleeding |
US5376067A (en) * | 1992-10-28 | 1994-12-27 | Daneshvar; Yousef | Pressure bandages and dressings |
US5514158A (en) * | 1992-12-28 | 1996-05-07 | Kanesaka; Nozomu | Sealing device for a percutaneous puncture |
US5827224A (en) * | 1995-11-22 | 1998-10-27 | Shippert; Ronald D. | Pressure applying fluid transfer medical device |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2312679A (en) * | 1941-10-23 | 1943-03-02 | Dill Mfg Co | Valve stem |
US2493326A (en) | 1949-03-01 | 1950-01-03 | John H Trinder | Tampon for control of intractable nasal hemorrhages |
US2847997A (en) | 1956-01-13 | 1958-08-19 | James J Tibone | Catheter |
US3049125A (en) | 1960-03-28 | 1962-08-14 | Kriwkowitsch George | Nose packing device |
US3420237A (en) | 1966-09-02 | 1969-01-07 | Martha K Fortay | Process and article for the treatment of severe epistaxis |
US3516407A (en) | 1968-04-25 | 1970-06-23 | Santo L Ruggero | Inflatable intranasal tampon |
GB1340788A (en) | 1971-02-04 | 1974-01-30 | Matburn Holdings Ltd | Nasal tampons |
US4418524A (en) * | 1980-06-19 | 1983-12-06 | Kao Soap Co., Ltd. | Twisted yarn and twisted bundle of yarns |
US4338941A (en) | 1980-09-10 | 1982-07-13 | Payton Hugh W | Apparatus for arresting posterior nosebleeds |
US4364392A (en) | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
US4638803A (en) | 1982-09-30 | 1987-01-27 | Rand Robert W | Medical apparatus for inducing scar tissue formation in a body |
US4581017B1 (en) * | 1983-03-07 | 1994-05-17 | Bard Inc C R | Catheter systems |
US4619261A (en) | 1984-08-09 | 1986-10-28 | Frederico Guerriero | Hydrostatic pressure device for bleeding control through an inflatable, stitchable and retrievable balloon-net system |
DE3619197A1 (en) | 1986-06-07 | 1987-12-10 | Ethicon Gmbh | UPHOLSTERY IMPLANT |
US4686962A (en) | 1986-07-03 | 1987-08-18 | Habley Medical Technology Corporation | Disposable cartridge assembly for hypodermically implanting a genitourinary prosthesis |
US4832680A (en) | 1986-07-03 | 1989-05-23 | C.R. Bard, Inc. | Apparatus for hypodermically implanting a genitourinary prosthesis |
US4990139A (en) * | 1986-09-10 | 1991-02-05 | Jang G David | Tandem independently inflatable/deflatable multiple diameter balloon angioplasty catheter systems |
US4883465A (en) | 1988-05-24 | 1989-11-28 | Brennan H George | Nasal tampon and method for using |
US5224497A (en) | 1988-07-06 | 1993-07-06 | Ehlers Robert L | Method of removing diverticula in the colon |
US5100385A (en) | 1989-01-27 | 1992-03-31 | C. R. Bard, Inc. | Fast purge balloon dilatation catheter |
EP0574378B1 (en) | 1989-06-28 | 1995-11-08 | ZIMMON, David S. | Balloon tamponade devices |
US5061274A (en) | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
US5108421A (en) | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5176692A (en) | 1991-12-09 | 1993-01-05 | Wilk Peter J | Method and surgical instrument for repairing hernia |
GB9126193D0 (en) * | 1991-12-10 | 1992-02-12 | Courtaulds Plc | Cellulosic fibres |
US5480644A (en) | 1992-02-28 | 1996-01-02 | Jsf Consultants Ltd. | Use of injectable biomaterials for the repair and augmentation of the anal sphincters |
DK44193D0 (en) * | 1993-04-20 | 1993-04-20 | Euromed I S | SPECIAL CONNECTION AND ADMINISTRATIVE TO A SPECIAL CONNECTION OR SIMILAR |
US5312435A (en) | 1993-05-17 | 1994-05-17 | Kensey Nash Corporation | Fail predictable, reinforced anchor for hemostatic puncture closure |
US5486195A (en) | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
WO1995020916A1 (en) | 1994-02-01 | 1995-08-10 | Kensey Nash Corporation | Percutaneous drug dosing closure system |
US5545176A (en) | 1994-05-31 | 1996-08-13 | Murtfeldt; Robert L. | Wound dilatation device |
US5645566A (en) | 1995-09-15 | 1997-07-08 | Sub Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
US6306154B1 (en) * | 1997-06-18 | 2001-10-23 | Bhk Holding | Hemostatic system for body cavities |
US6274538B1 (en) * | 1997-11-10 | 2001-08-14 | The Procter & Gamble Company | Detergent compositions |
US7018392B2 (en) * | 1998-04-08 | 2006-03-28 | Arthrocare Corporation | Hemostatic system for body cavities |
US6706051B2 (en) * | 1998-04-08 | 2004-03-16 | Bhk Holding, Ltd. | Hemostatic system for body cavities |
US7790192B2 (en) * | 1998-08-14 | 2010-09-07 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US7544192B2 (en) * | 2003-03-14 | 2009-06-09 | Sinexus, Inc. | Sinus delivery of sustained release therapeutics |
-
2001
- 2001-11-28 US US09/998,524 patent/US7018392B2/en not_active Expired - Lifetime
-
2006
- 2006-02-28 US US11/364,965 patent/US20060271094A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3483859A (en) * | 1967-11-29 | 1969-12-16 | Fred E Pittman | String for marking bleeding in upper gastro-intestinal tract |
US3618607A (en) * | 1970-02-17 | 1971-11-09 | Johnson & Johnson | Saline fluid absorption and retention tampons and methods of making the same |
US4041948A (en) * | 1976-07-26 | 1977-08-16 | Johnson & Johnson | Digital tampon |
US5263966A (en) * | 1991-11-29 | 1993-11-23 | Yousef Daneshvar | Device for suppressing post-catheterization wound bleeding |
US5376067A (en) * | 1992-10-28 | 1994-12-27 | Daneshvar; Yousef | Pressure bandages and dressings |
US5514158A (en) * | 1992-12-28 | 1996-05-07 | Kanesaka; Nozomu | Sealing device for a percutaneous puncture |
US5827224A (en) * | 1995-11-22 | 1998-10-27 | Shippert; Ronald D. | Pressure applying fluid transfer medical device |
Cited By (133)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060271094A1 (en) * | 1998-04-08 | 2006-11-30 | Arthrocare Corporation | Hemostatic system for body cavities |
US20030120134A1 (en) * | 2001-11-02 | 2003-06-26 | Rao R. Bharat | Patient data mining for cardiology screening |
EP1626766A2 (en) * | 2003-05-28 | 2006-02-22 | Rose Biomedical Development Corporation | Inflatable nasal packing device with two non-elastic, flexible bags oversized relative to nasal cavities |
US7108706B2 (en) | 2003-05-28 | 2006-09-19 | Rose Biomedical Development Corporation | Inflatable nasal packing device with two non-elastic, flexible bags oversized relative to nasal cavities |
EP1626766A4 (en) * | 2003-05-28 | 2006-08-30 | Rose Biomedical Dev Corp | Inflatable nasal packing device with two non-elastic, flexible bags oversized relative to nasal cavities |
US8092779B2 (en) | 2003-07-25 | 2012-01-10 | Rubicor Medical, Llc | Post-biopsy cavity treatment implants and methods |
US7537788B2 (en) | 2003-07-25 | 2009-05-26 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20070299541A1 (en) * | 2003-07-25 | 2007-12-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US7780948B2 (en) | 2003-07-25 | 2010-08-24 | Rubicor Medical, Llc | Post biopsy cavity treatment implants and methods |
US20070299339A1 (en) * | 2003-07-25 | 2007-12-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US7744852B2 (en) | 2003-07-25 | 2010-06-29 | Rubicor Medical, Llc | Methods and systems for marking post biopsy cavity sites |
US8491630B2 (en) | 2003-07-25 | 2013-07-23 | Encapsule Medical, LLC. | Post-biopsy cavity treatment implants and methods |
US20070135711A1 (en) * | 2003-07-25 | 2007-06-14 | Rubicor Medical, Inc. | Methods and systems for marking post biopsy cavity sites |
US20050019262A1 (en) * | 2003-07-25 | 2005-01-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20050058721A1 (en) * | 2003-09-12 | 2005-03-17 | Hursey Francis X. | Partially hydrated hemostatic agent |
US20090299253A1 (en) * | 2003-09-12 | 2009-12-03 | Hursey Francis X | Blood clotting compositions and wound dressings |
US8252344B2 (en) | 2003-09-12 | 2012-08-28 | Z-Medica Corporation | Partially hydrated hemostatic agent |
US7534452B2 (en) | 2003-10-16 | 2009-05-19 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20080114329A1 (en) * | 2003-10-16 | 2008-05-15 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20050114613A1 (en) * | 2003-10-30 | 2005-05-26 | Takayuki Otani | Multi-chip package type memory system |
US20060200189A1 (en) * | 2003-12-05 | 2006-09-07 | Nance Edward J | Expandable percutaneous sheath |
US7780692B2 (en) | 2003-12-05 | 2010-08-24 | Onset Medical Corporation | Expandable percutaneous sheath |
US7713193B2 (en) | 2003-12-05 | 2010-05-11 | Onset Medical Corporation | Expandable percutaneous sheath |
US20060200188A1 (en) * | 2003-12-05 | 2006-09-07 | Nance Edward J | Expandable percutaneous sheath |
US8282664B2 (en) * | 2003-12-05 | 2012-10-09 | Onset Medical Corporation | Expandable percutaneous sheath |
US9241735B2 (en) * | 2003-12-05 | 2016-01-26 | Onset Medical Corporation | Expandable percutaneous sheath |
US20050125021A1 (en) * | 2003-12-05 | 2005-06-09 | Nance Edward J. | Expandable percutaneous sheath |
US20050124937A1 (en) * | 2003-12-05 | 2005-06-09 | Kick George F. | Expandable percutaneous sheath |
US10349976B2 (en) | 2003-12-05 | 2019-07-16 | Onset Medical, Inc. | Expandable percutaneous sheath |
US20060079727A1 (en) * | 2004-09-03 | 2006-04-13 | Rubicor Medical, Inc. | Short term post surgical cavity treatment devices and methods |
US10272231B2 (en) | 2004-09-09 | 2019-04-30 | Onset Medical Corporation | Expandable trans-septal sheath |
US8764704B2 (en) | 2004-09-09 | 2014-07-01 | Onset Medical Corporation | Expandable transluminal sheath |
US20060135981A1 (en) * | 2004-09-09 | 2006-06-22 | Jay Lenker | Expandable transluminal sheath |
US8348892B2 (en) | 2004-09-09 | 2013-01-08 | Onset Medical Corporation | Expandable transluminal sheath |
US20060135962A1 (en) * | 2004-09-09 | 2006-06-22 | Kick George F | Expandable trans-septal sheath |
US7892203B2 (en) | 2004-09-09 | 2011-02-22 | Onset Medical Corporation | Expandable transluminal sheath |
US9801619B2 (en) | 2004-09-09 | 2017-10-31 | Onset Medical Corporation | Expandable transluminal sheath |
US8597277B2 (en) | 2004-09-09 | 2013-12-03 | Onset Medical Corporation | Expandable transluminal sheath |
US7780629B2 (en) | 2004-10-15 | 2010-08-24 | Futurematrix Interventional, Inc. | Non-compliant medical balloon having an integral non-woven fabric layer |
US7914487B2 (en) | 2004-10-15 | 2011-03-29 | Futurematrix Interventional, Inc. | Non-compliant medical balloon having braided or knitted reinforcement |
US7682335B2 (en) | 2004-10-15 | 2010-03-23 | Futurematrix Interventional, Inc. | Non-compliant medical balloon having an integral non-woven fabric layer |
US8002741B2 (en) | 2004-10-15 | 2011-08-23 | Bard Peripheral Vascular, Inc. | Non-compliant medical balloon having an integral woven fabric layer |
US20060085022A1 (en) * | 2004-10-15 | 2006-04-20 | Kelli Hayes | Non-compliant medical balloon having an integral woven fabric layer |
US8353868B2 (en) | 2004-10-15 | 2013-01-15 | Bard Peripheral Vascular, Inc. | Medical balloon having strengthening rods |
US20070219490A1 (en) * | 2004-10-15 | 2007-09-20 | Futuremed Interventional, Inc. | Non-compliant medical balloon having an integral non-woven fabric layer |
US20060085023A1 (en) * | 2004-10-15 | 2006-04-20 | Davies William F Jr | Medical balloon having strengthening rods |
US8105275B2 (en) | 2004-10-15 | 2012-01-31 | Bard Peripheral Vascular, Inc. | Non-compliant medical balloon having an integral non-woven fabric layer |
US20080188805A1 (en) * | 2004-10-15 | 2008-08-07 | Futurematrix Interventional, Inc. | Medical balloon having strengthening rods |
US7309324B2 (en) | 2004-10-15 | 2007-12-18 | Futuremed Interventional, Inc. | Non-compliant medical balloon having an integral woven fabric layer |
US7354419B2 (en) | 2004-10-15 | 2008-04-08 | Futuremed Interventional, Inc. | Medical balloon having strengthening rods |
US8221351B2 (en) | 2004-10-15 | 2012-07-17 | Bard Peripheral Vascular, Inc. | Non-compliant medical balloon having an integral non-woven fabric layer |
US8257731B2 (en) | 2005-02-09 | 2012-09-04 | Z-Medica Corporation | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
US8512743B2 (en) | 2005-02-09 | 2013-08-20 | Z-Medica, Llc | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
US8557278B2 (en) | 2005-02-09 | 2013-10-15 | Z-Medica, Llc | Devices and methods for the delivery of blood clotting materials to bleeding wounds |
US20100121244A1 (en) * | 2005-02-09 | 2010-05-13 | Z-Medica Corporation | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
US9821084B2 (en) | 2005-02-15 | 2017-11-21 | Virginia Commonwealth University | Hemostasis of wound having high pressure blood flow using kaolin and bentonite |
US11167058B2 (en) | 2005-02-15 | 2021-11-09 | Virginia Commonwealth University | Hemostasis of wound having high pressure blood flow |
US20090209969A1 (en) * | 2005-03-02 | 2009-08-20 | C.R. Bard Inc | Expandable access sheath |
US7985235B2 (en) | 2005-06-22 | 2011-07-26 | Bard Peripheral Vascular, Inc. | Balloon dilation catheter having transition from coaxial lumens to non-coaxial multiple lumens |
US20090171277A1 (en) * | 2005-06-22 | 2009-07-02 | Futurematrix Interventional, Inc. | Balloon dilation catheter having transition from coaxial lumens to non-coaxial multiple lumens |
US7985236B2 (en) | 2005-07-05 | 2011-07-26 | Bard Peripheral Vascular, Inc. | Rapid exchange balloon dilation catheter having reinforced multi-lumen distal portion |
US20070016133A1 (en) * | 2005-07-05 | 2007-01-18 | Futurematrix Interventional, Inc. | Rapid exchange balloon dilation catheter having reinforced multi-lumen distal portion |
US20070167971A1 (en) * | 2006-01-17 | 2007-07-19 | Raymond Huey | Devices and methods for promoting the formation of blood clots in esophageal varices |
US8938898B2 (en) | 2006-04-27 | 2015-01-27 | Z-Medica, Llc | Devices for the identification of medical products |
US20070251849A1 (en) * | 2006-04-27 | 2007-11-01 | Denny Lo | Devices for the identification of medical products |
US9078782B2 (en) | 2006-05-26 | 2015-07-14 | Z-Medica, Llc | Hemostatic fibers and strands |
US20100233248A1 (en) * | 2006-05-26 | 2010-09-16 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US8202532B2 (en) | 2006-05-26 | 2012-06-19 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US8257732B2 (en) | 2006-05-26 | 2012-09-04 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US20070275073A1 (en) * | 2006-05-26 | 2007-11-29 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US8114433B2 (en) | 2006-05-26 | 2012-02-14 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US9333117B2 (en) | 2006-05-26 | 2016-05-10 | Z-Medica, Llc | Clay-based hemostatic agents and devices for the delivery thereof |
US8846076B2 (en) | 2006-05-26 | 2014-09-30 | Z-Medica, Llc | Hemostatic sponge |
US8343537B2 (en) | 2006-05-26 | 2013-01-01 | Z-Medica, Llc | Clay-based hemostatic agents and devices for the delivery thereof |
US8784876B2 (en) | 2006-05-26 | 2014-07-22 | Z-Medica, Llc | Clay-based hemostatic agents and devices for the delivery thereof |
US7968114B2 (en) | 2006-05-26 | 2011-06-28 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US8383148B2 (en) | 2006-05-26 | 2013-02-26 | Z-Medica, Llc | Clay-based hemostatic agents and devices for the delivery thereof |
US8460699B2 (en) | 2006-05-26 | 2013-06-11 | Z-Medica, Llc | Clay-based hemostatic agents and devices for the delivery thereof |
US11123451B2 (en) | 2006-05-26 | 2021-09-21 | Z-Medica, Llc | Hemostatic devices |
US10960101B2 (en) | 2006-05-26 | 2021-03-30 | Z-Medica, Llc | Clay-based hemostatic agents |
US9867898B2 (en) | 2006-05-26 | 2018-01-16 | Z-Medica, Llc | Clay-based hemostatic agents |
US10086106B2 (en) | 2006-05-26 | 2018-10-02 | Z-Medica, Llc | Clay-based hemostatic agents |
US20100228174A1 (en) * | 2006-05-26 | 2010-09-09 | Huey Raymond J | Clay-based hemostatic agents and devices for the delivery thereof |
US9827404B2 (en) | 2006-12-20 | 2017-11-28 | Onset Medical Corporation | Expandable trans-septal sheath |
US8337518B2 (en) | 2006-12-20 | 2012-12-25 | Onset Medical Corporation | Expandable trans-septal sheath |
US7722568B2 (en) | 2007-01-29 | 2010-05-25 | Onset Medical Corporation | Expandable intra-aortic balloon pump sheath |
US20100228077A1 (en) * | 2007-01-29 | 2010-09-09 | Onset Medical Corporation | Expandable intra-aortic balloon pump sheath |
US8900191B2 (en) | 2007-01-29 | 2014-12-02 | Onset Medical Corporation | Expandable intra-aortic balloon pump sheath |
US8900214B2 (en) | 2007-03-30 | 2014-12-02 | Onset Medical Corporation | Expandable trans-septal sheath |
US20080317831A1 (en) * | 2007-06-21 | 2008-12-25 | Denny Lo | Hemostatic sponge and method of making the same |
US8236221B2 (en) | 2007-08-06 | 2012-08-07 | Bard Peripheral Vascular, Inc. | Non-compliant medical balloon |
US8002744B2 (en) | 2007-08-06 | 2011-08-23 | Bard Peripheral Vascular, Inc | Non-compliant medical balloon |
US8313601B2 (en) | 2007-08-06 | 2012-11-20 | Bard Peripheral Vascular, Inc. | Non-compliant medical balloon |
US20090162406A1 (en) * | 2007-09-05 | 2009-06-25 | Z-Medica Corporation | Wound healing with zeolite-based hemostatic devices |
US20090149700A1 (en) * | 2007-11-02 | 2009-06-11 | Ruben Garcia | Method and apparatus for pubic sling insertion |
US8562559B2 (en) | 2008-05-14 | 2013-10-22 | Onset Medical Corporation | Expandable iliac sheath and method of use |
US9387314B2 (en) | 2008-05-14 | 2016-07-12 | Onset Medical Corporation | Expandable iliac sheath and method of use |
US8668668B2 (en) | 2008-05-14 | 2014-03-11 | Onset Medical Corporation | Expandable iliac sheath and method of use |
US8728153B2 (en) | 2008-05-14 | 2014-05-20 | Onset Medical Corporation | Expandable transapical sheath and method of use |
US20090287182A1 (en) * | 2008-05-14 | 2009-11-19 | Onset Medical Corporation | Expandable iliac sheath and method of use |
US20090287183A1 (en) * | 2008-05-14 | 2009-11-19 | Onset Medical Corporation | Expandable transapical sheath and method of use |
US20110144690A1 (en) * | 2008-05-14 | 2011-06-16 | Onset Medical Corporation | Expandable transapical sheath and method of use |
US9440054B2 (en) | 2008-05-14 | 2016-09-13 | Onset Medical Corporation | Expandable transapical sheath and method of use |
US9433766B2 (en) | 2008-05-14 | 2016-09-06 | Onset Medical Corporation | Expandable iliac sheath and method of use |
US20100145267A1 (en) * | 2008-11-10 | 2010-06-10 | Onset Medical Corporation | Expandable spinal sheath and method of use |
US7951110B2 (en) | 2008-11-10 | 2011-05-31 | Onset Medical Corporation | Expandable spinal sheath and method of use |
US9044577B2 (en) | 2008-11-10 | 2015-06-02 | Onset Medical Corporation | Expandable spinal sheath and method of use |
US8728110B2 (en) | 2009-01-16 | 2014-05-20 | Bard Peripheral Vascular, Inc. | Balloon dilation catheter shaft having end transition |
US8814899B2 (en) | 2009-02-23 | 2014-08-26 | Futurematrix Interventional, Inc. | Balloon catheter pressure relief valve |
US9259559B2 (en) | 2009-02-23 | 2016-02-16 | Futurematrix Interventional, Inc. | Balloon catheter pressure relief valve |
US10188838B2 (en) | 2009-08-24 | 2019-01-29 | Cook Medical Technologies Llc | Textile-reinforced high-pressure balloon |
US9211391B2 (en) | 2009-09-24 | 2015-12-15 | Bard Peripheral Vascular, Inc. | Balloon with variable pitch reinforcing fibers |
US20120071913A1 (en) * | 2010-09-21 | 2012-03-22 | Tamez Oscar A | Nasal splints |
US9889154B2 (en) | 2010-09-22 | 2018-02-13 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
US8858969B2 (en) | 2010-09-22 | 2014-10-14 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
US11007218B2 (en) | 2010-09-22 | 2021-05-18 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
US8597240B2 (en) | 2011-02-02 | 2013-12-03 | Futurematrix Interventional, Inc. | Coaxial catheter shaft having balloon attachment feature with axial fluid path |
US9603964B2 (en) | 2012-06-22 | 2017-03-28 | Z-Medica, Llc | Hemostatic devices |
US9352066B2 (en) | 2012-06-22 | 2016-05-31 | Z-Medica, Llc | Hemostatic devices |
US11559601B2 (en) | 2012-06-22 | 2023-01-24 | Teleflex Life Sciences Limited | Hemostatic devices |
US10960100B2 (en) | 2012-06-22 | 2021-03-30 | Z-Medica, Llc | Hemostatic devices |
US9072806B2 (en) | 2012-06-22 | 2015-07-07 | Z-Medica, Llc | Hemostatic devices |
US9861414B2 (en) * | 2013-09-09 | 2018-01-09 | Globus Medical, Inc. | Percutaneous bone screw device |
US10149709B2 (en) * | 2013-09-09 | 2018-12-11 | Globus Medical, Inc. | Percutaneous bone screw device |
US9867645B2 (en) * | 2013-09-09 | 2018-01-16 | Globus Medical, Inc | Percutaneous bone screw device |
US20170086896A1 (en) * | 2013-09-09 | 2017-03-30 | Globus Medical, Inc. | Percutaneous bone screw device |
US9545280B2 (en) * | 2013-09-09 | 2017-01-17 | Globus Medical, Inc. | Percutaneous bone screw device |
US9480516B2 (en) * | 2013-09-09 | 2016-11-01 | Globus Medical, Inc. | Percutaneous bone screw device and method |
US20150073487A1 (en) * | 2013-09-09 | 2015-03-12 | Globus Medical, Inc. | Percutaneous bone screw device and method |
US10806476B2 (en) | 2017-11-12 | 2020-10-20 | David Awrey Randall | Anterior—posterior inflatable nosebleed packing |
US11596423B2 (en) | 2018-06-21 | 2023-03-07 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
KR20220011917A (en) * | 2020-07-22 | 2022-02-03 | 서울대학교병원 | self epistaxis control device |
KR102491963B1 (en) * | 2020-07-22 | 2023-01-27 | 서울대학교병원 | self epistaxis control device |
Also Published As
Publication number | Publication date |
---|---|
US20060271094A1 (en) | 2006-11-30 |
US7018392B2 (en) | 2006-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7018392B2 (en) | Hemostatic system for body cavities | |
US6706051B2 (en) | Hemostatic system for body cavities | |
EP0668086B1 (en) | Wound treating device | |
US6306154B1 (en) | Hemostatic system for body cavities | |
US5330446A (en) | Wound treating device using an inflatable membrane and method for treating wounds | |
US5370656A (en) | Throat pack | |
US6027478A (en) | Nasal cavity drainage and stoppage system | |
JP4691734B2 (en) | Device for selectively supplying a drug to a target position on the wall of a patient's body cavity, blood vessel or the like | |
US5720726A (en) | Balloon catheter having retention enhancements on the balloon | |
US3516407A (en) | Inflatable intranasal tampon | |
CN102834063B (en) | Post operative wound support device | |
US20020165581A1 (en) | Vascular sealing device and method | |
JP2004515300A (en) | Hemostatic device | |
JPH10505767A (en) | Catheter sleeve and method of using the same | |
CN210228244U (en) | Abdominal wall war wound hemostasis first aid device | |
CN110652350A (en) | Balloon assembly | |
KR102235362B1 (en) | Balloon catheter having chitosan hemostatic material | |
CN211327695U (en) | Double-sac drainage tube | |
CN210204839U (en) | Hemostasis device for general surgery department | |
CN217938294U (en) | Hemorrhoid compression hemostasis device providing observation visual field | |
CN218606705U (en) | Intranasal self-expansion retractor in nerve endoscopic skull base operation | |
CN216090660U (en) | Pressing device | |
CN216167656U (en) | Infusion of adjustable hemostasis pressurization pressure is pasted | |
CN214857282U (en) | ECMO collateral circulation puncture external member | |
CN219397426U (en) | Form, pressure adjustable intra-abdominal pressure hemostasis device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BHK HOLDING LTD, CAYMAN ISLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUDSON, JOHN OVERTON;BAUER, ALBERTO;REEL/FRAME:012622/0709;SIGNING DATES FROM 20020103 TO 20020114 |
|
AS | Assignment |
Owner name: ARTHROCARE CORPORATION, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BHK HOLDING;REEL/FRAME:016500/0475 Effective date: 20050816 |
|
AS | Assignment |
Owner name: BHK HOLDING, CAYMAN ISLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUDSON, JOHN OVERTON;BAUER, ALBERTO;SIGNING DATES FROM 20050812 TO 20050815;REEL/FRAME:016513/0037 Owner name: BHK HOLDING, CAYMAN ISLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUDSON, JOHN OVERTON;BAUER, ALBERTO;REEL/FRAME:016513/0037;SIGNING DATES FROM 20050812 TO 20050815 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A.,WASHINGTON Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:ARTHROCARE CORPORATION;REEL/FRAME:017105/0855 Effective date: 20060113 Owner name: BANK OF AMERICA, N.A., WASHINGTON Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:ARTHROCARE CORPORATION;REEL/FRAME:017105/0855 Effective date: 20060113 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: ARTHROCARE CORPORATION, TEXAS Free format text: RELEASE OF PATENT SECURITY AGREEMENT RECORDED AT REEL 017105 FRAME 0855;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:023180/0892 Effective date: 20060113 Owner name: ARTHROCARE CORPORATION,TEXAS Free format text: RELEASE OF PATENT SECURITY AGREEMENT RECORDED AT REEL 017105 FRAME 0855;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:023180/0892 Effective date: 20060113 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553) Year of fee payment: 12 |